Oxford Asset Management’s Avadel Pharmaceuticals AVDL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | – | Sell |
-26,706
| Closed | -$77K | – | 1700 |
|
|
2019
Q2 | $77K | Buy |
+26,706
| New | +$77K | ﹤0.01% | 1621 |
|
|
2018
Q3 | – | Sell |
-101,688
| Closed | -$623K | – | 1684 |
|
|
2018
Q2 | $623K | Sell |
101,688
-20,181
| -17% | -$124K | 0.01% | 1254 |
|
|
2018
Q1 | $888K | Sell |
121,869
-239,049
| -66% | -$1.74M | 0.02% | 988 |
|
|
2017
Q4 | $2.97M | Buy |
360,918
+71,717
| +25% | +$590K | 0.06% | 384 |
|
|
2017
Q3 | $2.94M | Sell |
289,201
-45,680
| -14% | -$464K | 0.06% | 420 |
|
|
2017
Q2 | $3.69M | Buy |
334,881
+129,044
| +63% | +$1.42M | 0.07% | 290 |
|
|
2017
Q1 | $1.99M | Sell |
205,837
-38,767
| -16% | -$375K | 0.05% | 479 |
|
|
2016
Q4 | $2.54M | Sell |
244,604
-42,945
| -15% | -$446K | 0.09% | 250 |
|
|
2016
Q3 | $3.57M | Sell |
287,549
-356
| -0.1% | -$4.42K | 0.11% | 231 |
|
|
2016
Q2 | $3.09M | Buy |
287,905
+126,791
| +79% | +$1.36M | 0.1% | 266 |
|
|
2016
Q1 | $1.78M | Buy |
+161,114
| New | +$1.78M | 0.05% | 396 |
|
|
2015
Q4 | – | Sell |
-23,950
| Closed | -$391K | – | 874 |
|
|
2015
Q3 | $391K | Buy |
+23,950
| New | +$391K | 0.01% | 524 |
|
|
2015
Q2 | – | Sell |
-39,413
| Closed | -$709K | – | 661 |
|
|
2015
Q1 | $709K | Buy |
+39,413
| New | +$709K | 0.02% | 507 |
|
|
2014
Q2 | – | Sell |
-74,053
| Closed | -$992K | – | 691 |
|
|
2014
Q1 | $992K | Buy |
+74,053
| New | +$992K | 0.03% | 457 |
|
|
2013
Q3 | – | Sell |
-12,089
| Closed | -$74K | – | 792 |
|
|
2013
Q2 | $74K | Buy |
+12,089
| New | +$74K | ﹤0.01% | 834 |
|